— Recent developments of interest in cardiovascular medicine
A study reevaluating genes reported to be associated with Brugada syndrome challenged the validity of all but one. (Circulation)
The American College of Cardiology renamed its ACTION Registry under the National Cardiovascular Data Registry umbrella to the Chest Pain - MI Registry, with a broader population to include unstable and low-risk angina.
There are too many excuses
for cardiologists not using the type 2 diabetes drugs shown to reduce cardiovascular events, two cardiologists argued in Circulation
Malnourished older adults are about three times more likely to die after aortic valve replacement, a study reported in Circulation.
Monkeys getting human embryonic stem cell-derived heart cells for heart failure saw a boost in heart function, a study reported in Nature Biotechnology.
"Cheap soda is no bargain," American Heart Association CEO Nancy Brown said in a statement from the organization supporting a future California ballot measure to tax sugary drinks statewide.
The Azure pacemaker with remote monitoring data sent directly to a smartphone or tablet via Bluetooth, instead of bedside device, is being studied to see whether compliance rates are any better. (Health Data Management)
Dr. Reddy's Laboratories is recalling more than 236,000 bottles of its atorvastatin in the U.S. due to impurities. (in-PharmaTechnologist.com)
Read the original article on Medpage Today: Brugada Genes Debunked; T2D Drug Excuses; Paradise Pivotal Trial